Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Durantel

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Antiviral Research|December 10, 2022
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virusMyriam Lamrayah, Fanny Charriaud, Manon Desmares, et al.
Hepatology (Baltimore, Md.)|May 26, 2005
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovirMarie-Noëlle Brunelle, Anne-Carole Jacquard, Christian Pichoud, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesisHao Zhang, Zheng Xing, Saravana Kumar Kailasam Mani, et al.
Hepatology (Baltimore, Md.)|March 20, 2010
Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate modelJulie Lucifora, Isabelle E Vincent, Pascale Berthillon, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2011
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibioticsSusan Obeid, Svetlana S Printsevskaya, Eugenia N Olsufyeva, et al.
JHEP Reports : Innovation in Hepatology|August 19, 2021
Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein productionJulie Lucifora, Florentin Pastor, Émilie Charles, et al.
Journal of Virological Methods|November 28, 2025
An alternative model for HEV infection in the HepaRG cell lineStacy Gellenoncourt, Marie Pellerin, Aïlona Marcadet-Hauss, et al.
Antiviral Research|August 13, 2022
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytesManon Desmares, Marion Delphin, Brieux Chardès, et al.
Antiviral Research|November 7, 2016
HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytesDulce Alfaiate, Julie Lucifora, Natali Abeywickrama-Samarakoon, et al.
Biochemical and Biophysical Research Communications|May 24, 2014
An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endotheliumRomain Parent, David Durantel, Thomas Lahlali, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Antiviral Research|December 10, 2022
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virusMyriam Lamrayah, Fanny Charriaud, Manon Desmares, et al.
Hepatology (Baltimore, Md.)|May 26, 2005
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovirMarie-Noëlle Brunelle, Anne-Carole Jacquard, Christian Pichoud, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesisHao Zhang, Zheng Xing, Saravana Kumar Kailasam Mani, et al.
Hepatology (Baltimore, Md.)|March 20, 2010
Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate modelJulie Lucifora, Isabelle E Vincent, Pascale Berthillon, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2011
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibioticsSusan Obeid, Svetlana S Printsevskaya, Eugenia N Olsufyeva, et al.
JHEP Reports : Innovation in Hepatology|August 19, 2021
Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein productionJulie Lucifora, Florentin Pastor, Émilie Charles, et al.
Journal of Virological Methods|November 28, 2025
An alternative model for HEV infection in the HepaRG cell lineStacy Gellenoncourt, Marie Pellerin, Aïlona Marcadet-Hauss, et al.
Antiviral Research|August 13, 2022
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytesManon Desmares, Marion Delphin, Brieux Chardès, et al.
Antiviral Research|November 7, 2016
HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytesDulce Alfaiate, Julie Lucifora, Natali Abeywickrama-Samarakoon, et al.
Biochemical and Biophysical Research Communications|May 24, 2014
An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endotheliumRomain Parent, David Durantel, Thomas Lahlali, et al.
Pageof 13